How Affinia Healthcare Helps Patients Achieve and Maintain Health Goals with GLP-1 Medications
Affinia Healthcare is dedicated to helping patients achieve and maintain their health goals through innovative solutions like GLP-1 medications. These medications, including Ozempic and Trulicity, effectively manage blood sugar levels for individuals with type 2 diabetes and support weight loss for those with obesity. By combining GLP-1 treatments with lifestyle changes, Affinia Healthcare is improving the overall well-being of its patients.
The Role of GLP-1 Medications in Weight Loss and Diabetes Management
The World Health Organization (WHO) recently endorsed GLP-1 medications for long-term obesity management. These medications can reduce the risk of related diseases, such as cardiovascular issues, hypertension, and kidney disease.
“GLP-1s can be used for DM2 management and also weight management for those with obesity,” said Dr. Melissa Tepe, Vice President and Chief Medical Officer at Affinia Healthcare. “There is potential for reduction in cardiovascular risk, hypertension, and kidney disease as well.”
Although GLP-1 medications are powerful, the WHO emphasizes that they work best when combined with other therapies and lifestyle changes. Affinia Healthcare provides resources to help patients make these changes, ensuring long-term success.
Comprehensive Support for Weight Loss and Health Goals
Affinia Healthcare goes beyond prescribing weight loss medications. They offer programs and resources that promote healthy living, such as:
- Walking Club: Encourages physical activity in a supportive community.
- Healthy Food Sources: Provides guidance on nutritious eating.
- Cooking Classes: Teaches patients how to prepare healthy meals at home.
“In addition to the GLP-1, patients have access to our Walking Club, healthy food sources, cooking class events, and much more,” added Dr. Tepe.
Addressing Barriers to Access in Black and Brown Communities
Despite the benefits of GLP-1 medications, barriers like accessibility and racial disparities have limited their use in Black and Brown communities. A study by the National Institute of Health highlights persistent racial and ethnic disparities in the use of obesity-management medications.
“At Affinia Healthcare, it’s important we continue to be a resource for everyone in our community, especially for the African American and Hispanic populations, who are known to have higher obesity rates versus their counterparts,” said Kenyatta Johnson, Director of Pharmacy at Affinia Healthcare. “Ensuring they have access to medications and other resources to help further their life span is important to the work we do daily.”
Convenient Pharmacy Locations for GLP-1 Prescriptions
Affinia Healthcare makes it easy for patients to access their prescriptions with three convenient pharmacy locations:
- 1717 Biddle Street
- 2220 Lemp Avenue
- 3396 Pershall Road (Ferguson)
For more information or to schedule an appointment, patients can call 314-814-8700.
Supporting the Community Through Holistic Care
Affinia Healthcare’s mission extends beyond medical treatment. As a 501(c)(3) non-profit organization, they are committed to serving the unmet healthcare needs of the most vulnerable populations in St. Louis. With over 43,700 patients served annually, Affinia Healthcare continues to be a beacon of hope for those in need.
To learn more about Affinia Healthcare’s services or to make a donation, visit their website at www.affiniahealthcare.org.
Related Resources for Weight Loss and Health
For additional insights on weight loss and health management, check out this article on The Narrative Matters about overcoming barriers to healthy living.
For more information on GLP-1 medications and their benefits, visit the World Health Organization’s guidelines on obesity management.
#HealthGoals #WeightLossJourney #DiabetesCare
